Copyright
©The Author(s) 2023.
World J Orthop. Apr 18, 2023; 14(4): 218-230
Published online Apr 18, 2023. doi: 10.5312/wjo.v14.i4.218
Published online Apr 18, 2023. doi: 10.5312/wjo.v14.i4.218
Table 5 Univariate analysis comparing demographic characteristics and reoperation rates between the primary distal femoral replacement and revision distal femoral replacement subgroups, n (%)
| Primary DFR (n = 29) | Revision DFR (n = 26) | P value | |
| Age (mean ± SD) | 49.7 ± 20.6 yr | 52.2 ± 21.1 yr | 0.649 |
| Gender | 0.44 | ||
| Male | 13 (44.8) | 9 (34.6) | |
| Female | 16 (55.2) | 17 (65.4) | |
| Body mass index (mean ± SD) | 29.5 ± 8.5 kg/m2 | 30.0 ± 8.4 kg/m2 | 0.567 |
| Follow-up (mean ± SD) | 42.7 ± 61.4 mo | 34.5 ± 47.5 mo | 0.946 |
| Complication requiring reoperation? | 11 (37.9) | 9 (34.6) | 0.799 |
| Total reoperations required (mean ± SD) | 1.4 ± 2.6 | 1.0 ± 1.8 | 0.624 |
- Citation: Christ AB, Chung BC, Urness M, Mayer LW, Gettleman BS, Heckmann ND, Menendez LR. Clinical outcomes of cemented distal femur replacements with all-polyethylene tibial components for oncologic indications. World J Orthop 2023; 14(4): 218-230
- URL: https://www.wjgnet.com/2218-5836/full/v14/i4/218.htm
- DOI: https://dx.doi.org/10.5312/wjo.v14.i4.218